Chronic diseases such as diabetes, cardiovascular disease, liver disease and others are becoming more and more common. The numbers released by the Centers for Disease Control and Prevention (CDC) show that in the United States, the rates of diabetes, cardiovascular disease, and liver disease are on the rise. This is why it’s very important for you to read and understand the research behind Chapter 6 in The Patient’s Guide to AHCC.
In this chapter of our extensive and thorough guide, you’ll learn how recent research into AHCC and chronic diseases is revealing how beneficial AHCC can be in reducing symptoms and side effects. You’ll learn more about how the ability of AHCC could have a positive impact on immune cells and immune response throughout the body, which opens the door for its use in treating many health challenges. In Chapter 6 of The Patient’s Guide to AHCC, we highlight recent promising research results into AHCC and chronic disease.
Diabetes is extremely prevalent, considering the following statistics:
- Data from the American Diabetes Association in 2011 reported that 25.8 million children and adults in the United States, have diabetes.
- An additional 79 million have pre-diabetes (meaning they are likely to develop the disease within a few years).
- Each year 1.9 million new cases of diabetes are diagnosed in people aged 20 and older.
- In 2010 the CDC forecasted that as many as one in three people in the United States could have diabetes by 2050.
The complications associated with diabetes are often debilitating and deadly as heart disease death rates are elevated. Diabetes is a serious cause of blindness in adults, the leading cause of kidney failure, and unfortunately many adults with diabetes also have hypertension.
Research indicates that both inflammation and oxidative stress are involved in type 2 diabetes. This inflammation appears to hinder the body’s ability to properly utilize insulin as well as contribute to the breakdown in the cells that produce insulin in the pancreas.
- AHCC has anti-inflammatory properties, so scientists have explored its use in animal models of diabetes.
- Turn to page 56 of Chapter 6: Other Chronic Diseases to learn about a recent study conducted at Dokkyo University School of Medicine in Saitama, Japan and a study conducted by researchers at Osaka University in Osaka, Japan comparing the treatment of rats with diabetes.
- As well, be sure to read about the study conducted by Dr. M. Iwamoto of Nobuyana Medical Corporation that involved 13 diabetic patients. In brief, all the individuals in the study took AHCC for more than six months and experienced significant declines in both average blood glucose levels and glycohemoglobin.
In an earlier chapter The Patient’s Guide to AHCC we highlighted how AHCC may help prevent liver damage in cancer patients who are undergoing chemotherapy. Other reports suggest AHCC may be helpful in treating serious liver diseases, such as acute liver failure and hepatitis:
- Acute liver failure is an uncommon but serious condition that has a high mortality rate.
- Hepatitis is an inflammation of the liver and also refers to a group of viruses that affect the organ.
- According to the CDC, in 2008, an estimated 4.4 million Americans were living with chronic hepatitis and approximately 80,000 new infections occur annually in the United States.
Acute liver failure is an uncommon condition in which the liver undergoes rapid deterioration in a previously healthy individual. This condition typically affects young people and has a mortality rate from 60 to 80 percent. On page 58, learn about a study conducted by scientists on the effect of AHCC in an animal model of acute liver failure.
Experts have also looked at possible benefits of AHCC in hepatitis patients. In some cases of hepatitis and liver cancer, patients and doctors report an improvement in the loss of platelets, a decrease or elimination of the viral load (the concentration of the virus in the blood) and cessation of the deterioration of liver function. Be sure to read page 58 in Chapter 6 of The Patient’s Guide to AHCC to learn about a case study of a 32-year old man who had chronic hepatitis B.
Cardiovascular diseases are the leading cause of death in the United States. According to the latest available figures from the American Heart Association, more than 81 million people in the United States have some form of cardiovascular disease and approximately 34 percent of all deaths are attributed to some form of heart disease.
AHCC possesses a few qualities that may help in the prevention of cardiovascular disease. We urge you to download The Patient’s Guide to AHCC and turn to page 59 to learn about AHCC and cardiovascular disease. Briefly, key studies show the anti-inflammatory properties of AHCC and associated CRP levels and the ability of AHCC to increase the production of nitric oxide.
Turn to pages 60 and 61 of The Patient’s Guide to AHCC to learn about a range of other ailments and disease that AHCC may be beneficial in treating. Learn about how AHCC could contribute to treating arthritis, amyotrophic lateral sclerosis, colitis, HIV/AIDS, glaucoma, hypertension, and chronic fatigue syndrome.
At this point, we are really touching the tip of an iceberg here with the benefits of AHCC - despite more than two decades of research, the full scope of the benefits people can reap from AHCC has hardly been realized. The research into AHCC and how it can be used to help reduce the impacts of serious disease is ongoing and we continue to see promising results. Because AHCC can impact the body’s immunity at a very basic level, the possibilities appear to be quite substantial. We want you to learn and experience the benefits AHCC can have on your health and well-being, do download the free The Patient’s Guide to AHCC so that you can fully understand how AHCC can make a difference in your life.